Seller record · pinnaclepeptides.com

Pinnacle Peptides

Recorded September 2026 · Standard v1.1

Fails 5 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed on any of the nine pages read, and every product page carries a research-use-only notice. 4 more criteria also fail; see the table below.

Research vendor. Passes 3 of 8 criteria. Recorded against Standard v1.1.

A research peptide and chemical seller trading since 2010, offering peptides, GLP-1 analogues and research liquids. The only postal address it publishes is in Panama, and an FDA letter addressed to it prints a North Carolina street address instead.

Operating entity The footer, the contact page, the customer-service page and the privacy policy were all read, and none of the four prints a legal entity name.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	pinnaclepeptides.com/faq
S2	Prescription gating	FAIL	pinnaclepeptides.com/checkout/cart
S3	Pharmacy identification	FAIL	pinnaclepeptides.com/faq
S4	Compounding disclosure	PASS	pinnaclepeptides.com/pinnacle-research-company
S5	Analytical documentation	FAIL	pinnaclepeptides.com/faq
S6	Business address	FAIL	pinnaclepeptides.com/contact
S7	Price disclosure	PASS	pinnaclepeptides.com/buy-ipamorelin-5mg.html
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician evaluation is claimed on any of the nine pages read, and every product page carries a research-use-only notice.Source: pinnaclepeptides.com/faq.

S2FAILThe order path was walked from the ipamorelin page at 34.99 dollars into a cart carrying that item, and no screen asked an eligibility question.Source: pinnaclepeptides.com/checkout/cart.

S3FAILNo pharmacy is named on any of the nine pages read, and a footer notice states that the seller is not a compounding pharmacy under section 503A.Source: pinnaclepeptides.com/faq.

S4PASSThe seller offers no compounded drug, the words compounded and compounding appear on none of the nine pages read, and a footer notice disclaims any compounding role.Source: pinnaclepeptides.com/pinnacle-research-company.

S5FAILThe questions page explains how purity is measured and guarantees above 99 percent, and no certificate, chromatogram or lot report is reachable from any of the nine pages read.Source: pinnaclepeptides.com/faq.

S6FAILThe only postal address printed on any page read is a mailing address in Panama City, Panama, and no United States address appears anywhere on the site.Source: pinnaclepeptides.com/contact.

S7PASSThe ipamorelin page prints 34.99 dollars for one 5 mg vial with quantity tiers falling to 24.49 dollars, visible with no account.Source: pinnaclepeptides.com/buy-ipamorelin-5mg.html.

S8PASSFDA warning letter 719337, December 2025, names Pinnacle Professional Research doing business as Pinnacle Peptides and alleges its products marketed as selective androgen receptor modulators are unapproved new drugs. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including semaglutide, tirzepatide, BPC-157 and ipamorelin, peptide blends, research liquids, selective androgen receptor modulators, diluents.

Enforcement documents on file: 1 warning letter

FDA warning letter 719337, issued December 2025, to Pinnacle Professional Research dba Pinnacle PeptidesThe products marketed as selective androgen receptor modulators on pinnaclepeptides.com are unapproved new drugs intended for human use, despite research-only labeling.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Sellers passing S1, prescriber requirement

Records dated August 2026

Records dated September 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.